These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7628323)

  • 21. Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study.
    Bassotti G; D'Onofrio V; Battaglia E; Fiorella S; Dughera L; Iaquinto G; Mazzocchi A; Morelli A; Annese V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1615-9. PubMed ID: 16696811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
    Katzka DA; Castell DO
    Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophageal perforation, inflammatory mediastinitis and pseudoaneurysm of the thoracic aorta as potential complications of botulinum toxin injection for achalasia.
    Chao CY; Raj A; Saad N; Hourigan L; Holtmann G
    Dig Endosc; 2015 Jul; 27(5):618-21. PubMed ID: 25329507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal heart block following treatment with botulinum toxin for achalasia.
    Malnick SD; Metchnik L; Somin M; Bergman N; Attali M
    Am J Gastroenterol; 2000 Nov; 95(11):3333-4. PubMed ID: 11095386
    [No Abstract]   [Full Text] [Related]  

  • 25. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
    Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
    Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
    Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
    Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital cricopharyngeal achalasia: management with botulinum toxin before myotomy.
    Sewell RK; Bauman NM
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):451-3. PubMed ID: 15897426
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of botulin A toxin in achalasia.
    al Karawi MA; Ahmed AM; Ghandour Z
    Endoscopy; 1995 Feb; 27(2):217. PubMed ID: 7601063
    [No Abstract]   [Full Text] [Related]  

  • 29. Achalasia associated with multiple esophageal diverticula.
    Kim Y; Kim JH; Kim C; Park H
    Endoscopy; 2009; 41 Suppl 2():E47-8. PubMed ID: 19288420
    [No Abstract]   [Full Text] [Related]  

  • 30. Review article: the management of achalasia - a comparison of different treatment modalities.
    Lake JM; Wong RK
    Aliment Pharmacol Ther; 2006 Sep; 24(6):909-18. PubMed ID: 16948803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin for suspected pseudoachalasia.
    Vallera RA; Brazer SR
    Am J Gastroenterol; 1995 Aug; 90(8):1319-21. PubMed ID: 7639237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial.
    Pasricha PJ; Ravich WJ; Hendrix TR; Sostre S; Jones B; Kalloo AN
    Ann Intern Med; 1994 Oct; 121(8):590-1. PubMed ID: 8085691
    [No Abstract]   [Full Text] [Related]  

  • 33. Achalasia.
    Dughera L; Cassolino P; Cisarò F; Chiaverina M
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):277-85. PubMed ID: 18614976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary retention secondary to detrusor muscle hypofunction after botulinum toxin injection for achalasia.
    Khurana V; Nehme O; Khurana R; Barkin JS
    Am J Gastroenterol; 2001 Nov; 96(11):3211-2. PubMed ID: 11721783
    [No Abstract]   [Full Text] [Related]  

  • 35. Symptomatic gastroparesis in a patient with achalasia.
    Gutierrez-Galiana E; Botoman VA; Bech H
    J Clin Gastroenterol; 1998 Sep; 27(2):166-8. PubMed ID: 9754785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of botulinum toxin type A in the prophylactic treatment of migraine headaches.
    Chilson CN; Brown SJ
    Ann Pharmacother; 2005 Dec; 39(12):2081-5. PubMed ID: 16264063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of botulinum toxin in gastrointestinal disorders].
    Zepeda-Gómez S; Valdovinos-Díaz MA
    Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified method of botulinum toxin injection in patients with achalasia: a pilot trial.
    Martínek J; Spicàk J
    Endoscopy; 2003 Oct; 35(10):841-4. PubMed ID: 14551862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the management of achalasia: balloons, surgery and drugs.
    Richter JE
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):435-45. PubMed ID: 19072391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Achalasia--inject or dilate?].
    von Schönfeld J
    Z Gastroenterol; 1999 Oct; 37(10):1075-6. PubMed ID: 10549102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.